VAM
ARRY

Visium Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Visium Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,525,000
Closed -$4.5M – 547
2016
Q1 		$4.5M Sell
1,525,000
-475,000
-24% -$1.42M 0.08% 277
2015
Q4 		$8.44M Buy
2,000,000
+1,988,700
+17,599% +$9.08M 0.13% 199
2015
Q3 		$52K Buy
+11,300
New +$67K ﹤0.01% 869

Other funds holding ARRY

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Visium Asset Management's ARRY Position: Q2 2016 in Review

Visium Asset Management sold out of Array Biopharma Inc (ARRY) in Q2 2016, closing a stake of 1,525,000 shares — an estimated $4.5M sold.

Visium Asset Management first reported a position in ARRY in Q3 2015 and held it in 3 quarters. The position peaked at $8.44M in Q4 2015. 128 funds tracked by Wall St. Rank hold ARRY as of Q2 2016.

  • Visium Asset Management reported no remaining Array Biopharma Inc position as of Q2 2016 after selling out during the quarter.
  • Visium Asset Management sold 1,525,000 Array Biopharma Inc shares in Q2 2016, an estimated $4.5M.
  • Visium Asset Management first reported a position in Array Biopharma Inc in Q3 2015 and held it in 3 quarters.
  • Visium Asset Management's Array Biopharma Inc position peaked at $8.44M in Q4 2015.
  • 128 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.